spacer
Indus Biotherapeutics Ltd. Indus Biotherapeutics Ltd.
Indus Biotherapeutics Give your Feedback to Indus Biotherapeutics Sitemap Feel free to Contact Us
Home   Feedback   Sitemap   Contact  
   
 

We believe in providing the best in terms of
quality products and professional services...

Home » Products & Services » rHu G-CSF - Information for healthcare Professionals
 
NEUKINEŽ- RECOMBINANT HUMAN GRANULOCYTE COLONY STIMULATING FACTOR (rHu G-CSF) Injection (Filgrastim Injection)
Find Products & Services:
Each 1-ml prefilled syringe contains:
Recombinant Human G-CSF –300 mcg
Description:
Neukine Recombinant G-CSF (Filgrastim), the active ingredient of Neukine, is a 175 amino acid protein manufactured by recombinant DNA technology. It is produced by Escherichia coli (E. coli) bacteria into which the human granulocyte colony-stimulating factor gene has been inserted. Recombinant G-CSF has a molecular weight of 18,800 Daltons. The protein has an amino acid sequence that is identical to the natural GCSF except for the addition of an N-terminal methionine necessary for expression in E.coli.

Content

Neukine (1.0 ml Prefilled Syringe/

rHu G-CSF

300 mcg

Acetate

0.59 mg

Sorbitol

50.0 mg

Tween 80

0.004 %

Sodium

0.035 mg

Water

1.0 ml WFI

pH

4.0

G-CSF - Information for Professionals:
Preclinical Pharmacology
Clinical Pharmacology
Pharmacologic Effects of Recombinant G-CSF
Pharmacokinetics
Clinical Effects
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied

For further details and product specifications please contact us.

 
Top
  info@indusbio.co.in Designed by : Semaphore Infotech Pvt. Ltd  
spacer